Appointments
Raremark has appointed Caroline O’Connor as its new Chief Commercial Officer.
Previously holding the position of Raremark’s Senior Vice...
Scenic Biotech has announced the appointment of Dr Philippe Dro as its independent Chairman. Dr Dro replaces Dr Ulrich Grau, who retires from the...
Raremark, a global healthtech company specialising in rare disease, has appointed Nicki Grundy as Chief Financial Officer.
As a key member...
Purespring Therapeutics, a kidney-focused AAV gene therapy company, has announced it will appoint Richard Francis as Chief Executive Officer from...
Clinigen, the global pharmaceutical and services company, has appointed Sam Herbert as Chief Operating Officer with immediate effect.
...
PureTech Health, a clinical-stage biotherapeutics company focused on highly differentiated medicines for devastating diseases, has appointed Dr...
Novavax, a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, has announced the appointment of...
4BIO Capital, an international venture capital firm focused on advanced therapies addressing high unmet medical and social needs, has appointed...
Ionis Pharmaceuticals has announced that its founder, Dr Stanley T Crooke, will retire from the company and its board of directors effective June...
Sage Therapeutics, a biopharmaceutical company focused on developing treatments for central nervous system disorders, has appointed Barry Greene...